21- Rouet P, Smih F, Jasin M. Introduction of double-strand breaks into the genome of mouse
cells by expression of a rare-cutting endonuclease. Mol Cell Biol. 1994;14:8096–106. - Yanik M, et al. In vivo genome editing as a potential treatment strategy for inherited retinal
dystrophies. Prog Retin Eye Res. doi:10.1016/j.preteyeres.2016.09.001. - Chandrasegaran S, Smith J. Chimeric restriction enzymes: what is next? Biol Chem.
1999;380:841–8. - Kim YG, Shi Y, Berg JM, Chandrasegaran S. Site-specific cleavage of DNA-RNA hybrids by
zinc finger/FokI cleavage domain fusions. Gene. 1997;203:43–9. - Kim YG, Cha J, Chandrasegaran S. Hybrid restriction enzymes: zinc finger fusions to Fok I
cleavage domain. Proc Natl Acad Sci U S A. 1996;93:1156–60. - Gaj T, Gersbach CA, Barbas CF. ZFN, TALEN, and CRISPR/Cas-based methods for genome
engineering. Trends Biotechnol. 2013;31:397–405. - Urnov FD, et al. Highly efficient endogenous human gene correction using designed zinc-
finger nucleases. Nature. 2005;435:646–51. - Schierling B, et al. A novel zinc-finger nuclease platform with a sequence-specific cleavage
module. Nucleic Acids Res. 2012;40:2623–38. - Boch J, et al. Breaking the code of DNA binding specificity of TAL-type III effectors.
Science. 2009;326:1509–12. - Scholze H, Boch J. TAL effectors are remote controls for gene activation. Curr Opin
Microbiol. 2011;14:47–53. - Christian M, et al. Targeting DNA double-strand breaks with TAL effector nucleases.
Genetics. 2010;186:757–61. - Miller JC, et al. A TALE nuclease architecture for efficient genome editing. Nat Biotechnol.
2011;29:143–8. - Holkers M, et al. Differential integrity of TALE nuclease genes following adenoviral and
lentiviral vector gene transfer into human cells. Nucleic Acids Res. 2013;41:e63. - Ishino Y, Shinagawa H, Makino K, Amemura M, Nakata A. Nucleotide sequence of the iap
gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and iden-
tification of the gene product. J Bacteriol. 1987;169:5429–33. - Nakata A, Amemura M, Makino K. Unusual nucleotide arrangement with repeated sequences
in the Escherichia coli K-12 chromosome. J Bacteriol. 1989;171:3553–6. - Mojica FJ, Díez-Villaseñor C, Soria E, Juez G. Biological significance of a family of regu-
larly spaced repeats in the genomes of archaea, bacteria and mitochondria. Mol Microbiol.
2000;36:244–6. - Makarova KS, et al. Evolution and classification of the CRISPR–Cas systems. Nat Rev
Microbiol. 2011;9:467–77. - Jansen R, van Embden JDA, Gaastra W, Schouls LM. Identification of a novel family of
sequence repeats among prokaryotes. OMIC. 2002;6:23–33. - Karginov FV, Hannon GJ. The CRISPR system: small RNA-guided defense in bacteria and
archaea. Mol Cell. 2010;37:7–19. - Jinek M, et al. A programmable dual-RNA–guided DNA endonuclease in adaptive bacterial
immunity. Science. 2012;337:816–21. - Zhang, Y. et al. Comparison of non-canonical PAMs for CRISPR/Cas9-mediated DNA cleav-
age in human cells. Sci Rep. 2014; 4. - Jinek M, et al. Structures of Cas9 endonucleases reveal RNA-mediated conformational acti-
vation. Science. 2014;343:1247997. - Makarova KS, et al. An updated evolutionary classification of CRISPR-Cas systems. Nat Rev
Microbiol. 2015;13:722–36. - Mali P, et al. RNA-guided human genome engineering via Cas9. Science. 2013;339:823–6.
- Cong L, et al. Multiplex genome engineering using CRISPR/Cas systems. Science.
2013;339:819–23. - Osborn MJ, et al. Fanconi anemia gene editing by the CRISPR/Cas9 system. Hum Gene Ther.
2015;26:114–26.
1 Viral Vectors, Engineered Cells and the CRISPR Revolution